BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 30640743)

  • 1. Liver stiffness measurement changes following hepatocellular carcinoma treatment with percutaneous microwave ablation or transarterial chemoembolization: a cohort study.
    Abdelaziz AO; Abdelhalim H; Elsharkawy A; Shousha HI; Abdelmaksoud AH; Soliman ZA; Seif MI; Sayed DB; Farouk MH; Elbaz TM; Nabeel MM
    Eur J Gastroenterol Hepatol; 2019 Jun; 31(6):685-691. PubMed ID: 30640743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A nomogram to predict survival of patients with intermediate-stage hepatocellular carcinoma after transarterial chemoembolization combined with microwave ablation.
    Ni JY; Fang ZT; Sun HL; An C; Huang ZM; Zhang TQ; Jiang XY; Chen YT; Xu LF; Huang JH
    Eur Radiol; 2020 Apr; 30(4):2377-2390. PubMed ID: 31900694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the Efficacy and Prognostic Factors of Transarterial Chemoembolization Plus Microwave Ablation versus Transarterial Chemoembolization Alone in Patients with a Large Solitary or Multinodular Hepatocellular Carcinomas.
    Zheng L; Li HL; Guo CY; Luo SX
    Korean J Radiol; 2018; 19(2):237-246. PubMed ID: 29520181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination transarterial chemoembolization and microwave ablation improves local tumor control for 3- to 5-cm hepatocellular carcinoma when compared with transarterial chemoembolization alone.
    Smolock AR; Cristescu MM; Hinshaw A; Woo KM; Wells SA; Ziemlewicz TJ; Lubner MG; Dalvie PS; Louis Hinshaw J; Brace CL; Ozkan OS; Lee FT; Laeseke P
    Abdom Radiol (NY); 2018 Sep; 43(9):2497-2504. PubMed ID: 29450606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant cytokine-induced killer cells with minimally invasive therapies augmented therapeutic efficacy of unresectable hepatocellular carcinoma.
    Huang ZM; Lai CX; Zuo MX; An C; Wang XC; Huang JH; Ning E
    J Cancer Res Ther; 2020; 16(7):1603-1610. PubMed ID: 33565506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcatheter arterial chemoembolization combined with simultaneous DynaCT-guided microwave ablation in the treatment of small hepatocellular carcinoma.
    Li Z; Jiao D; Han X; Si G; Li Y; Liu J; Xu Y; Zheng B; Zhang X
    Cancer Imaging; 2020 Jan; 20(1):13. PubMed ID: 32000862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis on efficacy and safety of TACE in combination with RFA and MWA in the treatment of middle and large primary hepatic carcinoma.
    Yuan P; Zhang Z; Kuai J
    J BUON; 2019; 24(1):163-170. PubMed ID: 30941966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transarterial Chemoembolization Monotherapy Versus Combined Transarterial Chemoembolization-Microwave Ablation Therapy for Hepatocellular Carcinoma Tumors ≤5 cm: A Propensity Analysis at a Single Center.
    Chen QF; Jia ZY; Yang ZQ; Fan WL; Shi HB
    Cardiovasc Intervent Radiol; 2017 Nov; 40(11):1748-1755. PubMed ID: 28681222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma.
    Ni JY; Sun HL; Chen YT; Luo JH; Chen D; Jiang XY; Xu LF
    World J Gastroenterol; 2014 Dec; 20(46):17483-90. PubMed ID: 25516662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transarterial chemoembolization combined with microwave ablation and apatinib in patients with Barcelona clinic liver cancer Stage C hepatocellular carcinoma: A propensity score matching analysis.
    Shuanggang C; Shen L; Qiu Z; Qi H; Cao F; Xie L; Fan W
    J Cancer Res Ther; 2020; 16(2):250-257. PubMed ID: 32474509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microwave ablation of hepatocellular carcinoma with portal vein tumor thrombosis after transarterial chemoembolization: a prospective study.
    Long J; Zheng JS; Sun B; Lu N
    Hepatol Int; 2016 Jan; 10(1):175-84. PubMed ID: 26742761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transarterial chemoembolization combined with microwave ablation versus microwave ablation only for Barcelona clinic liver cancer Stage B hepatocellular carcinoma: A propensity score matching study.
    Li X; Chen B; An C; Cheng Z; Han Z; Liu F; Yu J; Liang P
    J Cancer Res Ther; 2020 Sep; 16(5):1027-1037. PubMed ID: 33004744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of albumin-bilirubin grade, platelet-albumin-bilirubin grade and Child-Turcotte-Pugh class for prediction of survival in patients with large hepatocellular carcinoma after transarterial chemoembolization combined with microwave ablation.
    Ni JY; Fang ZT; An C; Sun HL; Huang ZM; Zhang TQ; Jiang XY; Chen YT; Xu LF; Huang JH
    Int J Hyperthermia; 2019; 36(1):841-853. PubMed ID: 31452408
    [No Abstract]   [Full Text] [Related]  

  • 14. Radiofrequency vs Microwave Ablation After Neoadjuvant Transarterial Bland and Drug-Eluting Microsphere Chembolization for the Treatment of Hepatocellular Carcinoma.
    Thornton LM; Cabrera R; Kapp M; Lazarowicz M; Vogel JD; Toskich BB
    Curr Probl Diagn Radiol; 2017; 46(6):402-409. PubMed ID: 28392205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined transarterial chemoembolization and microwave ablation versus transarterial chemoembolization in BCLC stage B hepatocellular carcinoma.
    Zhang R; Shen L; Zhao L; Guan Z; Chen Q; Li W
    Diagn Interv Radiol; 2018 Jul; 24(4):219-224. PubMed ID: 29792289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microwave ablation with chemoembolization for large hepatocellular carcinoma in patients with cirrhosis.
    Hu H; Chen GF; Yuan W; Wang JH; Zhai B
    Int J Hyperthermia; 2018 Dec; 34(8):1351-1358. PubMed ID: 29720001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microwave ablation versus transarterial chemoembolization in large hepatocellular carcinoma: prospective analysis.
    Abdelaziz AO; Nabeel MM; Elbaz TM; Shousha HI; Hassan EM; Mahmoud SH; Rashed NA; Ibrahim MM; Abdelmaksoud AH
    Scand J Gastroenterol; 2015 Apr; 50(4):479-84. PubMed ID: 25592058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Combination Strategy of Transarterial Chemoembolization and Radiofrequency Ablation or Microwave Ablation against Hepatocellular Carcinoma.
    Xu Z; Xie H; Zhou L; Chen X; Zheng S
    Anal Cell Pathol (Amst); 2019; 2019():8619096. PubMed ID: 31534899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationality and effectiveness of transarterial chemoembolization as an initial treatment for BCLC B stage HBV-related hepatocellular carcinoma.
    Heng-jun G; Yao-jun Z; Min-shan C; Mei-xian C; Jun-ting H; Li X; Lau WY
    Liver Int; 2014 Apr; 34(4):612-20. PubMed ID: 24028297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver stiffness measurement in patients with cirrhosis and hepatocellular carcinoma: a case-control study.
    Nahon P; Kettaneh A; Lemoine M; Seror O; Barget N; Trinchet JC; Beaugrand M; Ganne-Carrié N
    Eur J Gastroenterol Hepatol; 2009 Feb; 21(2):214-9. PubMed ID: 19212210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.